UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000015761
Receipt No. R000018341
Official scientific title of the study A Randomized, Double-blind, Placebo-controlled Study on the Anti-Obesity Effect of Food Containing Rosehip Extract
Date of disclosure of the study information 2014/11/27
Last modified on 2019/03/05 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study A Randomized, Double-blind, Placebo-controlled Study on the Anti-Obesity Effect of Food Containing Rosehip Extract
Title of the study (Brief title) The Anti-Obesity Effect of Food Containing Rosehip Extract
Region
Japan

Condition
Condition No (Subjects whose BMI are 25 to 30)
Classification by specialty
Not applicable Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To examine the anti-obesity effect of food containing rosehip extract on body fat
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Abdominal fat area
Body fat percent
Key secondary outcomes Weight
BMI
Blood pressure
Heart rate
Waist circumference
Hip circumference
Skinfold thickness

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 Tablet containing 100mg of rosehip extract, 1 per serving per day for 12 weeks
Interventions/Control_2 Tablet not containing rosehip extract, 1 per serving per day for 12 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria (1)Adult subjects whose BMI are 25 to 30
(2)Subjects giving written informed consent
Key exclusion criteria (1)Subjects who have allergic reaction to medicine.
(2)Subjects who smoke excessively and drink alcohol habitually, and whose eating habits are extremely irregular.
(3)Subjects who has liver dysfunction or renal dysfunction.
(4)Subjects who has history of surgery on gastrointestinal part such as gastrectomy, gastrointestinal suture, and intestinal resection.
(5)Subjects who donated 400 mL of blood within 12 weeks before starting of administration, or who donated 200 mL of blood within 4 weeks or donated blood component within 2 weeks.
(6)Midnight and irregular shift worker.
(7)Subjects who are during pregnancy, nursing, and who plan to become pregnant within six months.
(8)Subjects who are judged as unsuitable for the study by the investigator for other reason.
Target sample size 32

Research contact person
Name of lead principal investigator Ikuo Fukuhara
Organization Fukuhara clinic
Division name Medical office
Address 3-1-15 Shimamatsuhigashimachi, Eniwashi, Hokkaido
TEL 0123-36-8029
Email i-feniwa@gray.plala.or.jp

Public contact
Name of contact person Akifumi Nagatomo
Organization Morishita Jintan Co.,Ltd.
Division name Research and Development Division
Address Osaka Techno Center, 2-11-1, Tsudayamate, Hirakata, Osaka
TEL 072-800-1044
Homepage URL
Email a-nagatomo@jintan.co.jp

Sponsor
Institute Morishita Jintan Co.,Ltd.
Institute
Department

Funding Source
Organization Morishita Jintan Co.,Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 11 Month 27 Day

Progress
Recruitment status Completed
Date of protocol fixation
2011 Year 07 Month 04 Day
Anticipated trial start date
2011 Year 09 Month 15 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results https://doi.org/10.2147/DMSO.S78623
Results
Other related information

Management information
Registered date
2014 Year 11 Month 26 Day
Last modified on
2019 Year 03 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018341